河北医科大学学报 ›› 2025, Vol. 46 ›› Issue (8): 965-970.doi: 10.3969/j.issn.1007-3205.2025.08.016

• • 上一篇    下一篇

绝经后女性25-(OH)D、D-二聚体、PINP在PMOP中的诊断价值及相关性分析

  

  1. 上海市保健医疗中心老年病科,上海 214065

  • 出版日期:2025-08-25 发布日期:2025-08-29
  • 作者简介:朱正锴(1983-),男,安徽安庆人,上海市保健医疗中心主治医师,医学硕士,从事老年病科疾病诊治研究。

  • 基金资助:
    上海市保健医疗中心面上项目(2024005)

Diagnostic value and correlation analysis of 25-(OH)D, D-dimer and PINP in PMOP in postmenopausal women

  1. Department of Geriatrics, Shanghai Health and Medical Center, Shanghai 214065, China

  • Online:2025-08-25 Published:2025-08-29

摘要: 目的 分析绝经后女性25- 羟维生素 D[25-hydroxyvitamin D,25-(OH)D]、D - 二聚体(D-dimer,DD)、Ⅰ型原胶原氨基端前肽(procollagen type Ⅰ N-terminal propeptide,PINP)在绝经后骨质疏松症(postmenopausal osteoporosis,PMOP)中的诊断价值及相关性。
方法 收集2022年1月—2024年12月在上海市保健医疗中心体检中心进行健康体检的绝经后女性255例作为研究对象,按最低骨密度T值分为3组:正常组(T-值≥-1.0),骨量减少组(-2.5<T-值<-1. 0),骨质疏松组(T-值≤-2.5)。对比3组血清25-(OH)D、D-二聚体、PINP浓度,通过Pearson相关分析绝经后女性血清25-(OH)D、DD、PINP浓度与L1~4骨密度、股骨颈骨密度、左髋骨密度的相关性,通过受试者工作特征(receiver operating characteristic,ROC)曲线分析血清25-(OH)D、 DD、PINP在PMOP中的诊断效能。
结果 骨质疏松组年龄(59.98±3.49)岁、绝经时间(7.28±2.39)年相较于正常组(52.76±3.87)岁、(2.90±2.57)年及骨量减少组(55.02±4.18)岁、(4.52±2.99)年均明显增加,L1~4总和骨密度(0.730±0.064) g/cm2、股骨颈骨密度(0.680±0.057) g/cm2、左髋总和骨密度(0.868±0.059)g/cm2相较于正常组均明显降低(P<0.05);骨质疏松组年龄、绝经时间相较于骨量减少组均明显增加,L1~4总和骨密度、股骨颈骨密度、左髋总和骨密度相较于骨量减少组均明显降低(P<0.05)。骨质疏松组 25-(OH) D(17.70±7.28 )μg/L显著低于骨量减少组(21.15±4.88)μg/L及正常组(25.43±4.15)μg/L,DD(0.52±0.16)mg/L、PINP(67.94±15.76)μg/L显著高于另外2组(P<0.05);骨质疏松组25-(OH)D浓度相较于骨量减少组均明显降低,DD、PINP浓度相较于骨量减少组均明显增加(P<0.05)。Pearson相关分析发现,绝经后女性血清25-(OH)D浓度与L1~4总和骨密度、股骨颈骨密度、左髋总和骨密度均呈正相关(P<0.001);血清DD、PINP浓度与L1~4总和骨密度、股骨颈骨密度、左髋总和骨密度呈负相关(P<0.001)。25-(OH) D、DD、PINP 及联合诊断的 AUC 分别为 0.765、0.852、0.712、0.968,血清25-(OH)D、DD、PINP在诊断PMOP中均具有一定价值,联合诊断敏感度(96.7%)、特异度(88.2%)且联合诊断价值明显优于血清指标单一诊断(Z=7.036、12.927、5.219、43.446,均P<0.05)。
结论 血清25-(OH)D、DD及PINP水平与不同部位骨密度密切相关,在PMOP诊断中具有一定的诊断价值,且联合诊断价值更高。


关键词: 骨质疏松, 绝经后, 骨化二醇, D-二聚体

Abstract: Objective To analyze the diagnostic value and correlation of 25-hydroxyvitamin D [25-(OH)D], D-dimer (DD), and procollagen Type Ⅰ N-terminal propeptide (PINP) in postmenopausal osteoporosis (PMOP) in postmenopausal women. 
Methods A total of 255 postmenopausal women who underwent physical examinations in the Physical Examination Center of Shanghai Health and Medical Center from January 2022 to December 2024 were collected as research subjects and divided into three groups according to the lowest T value of bone mineral density (BMD): normal group (T value≥-1.0), osteopenia group (-2.5<T value<-1. 0), and osteoporosis group (T value≤-2.5). The serum 25-(OH)D, DD and PINP concentrations were compared among the three groups. The correlation between serum 25-(OH)D, DD and PINP concentrations and L1-4 BMD, femoral neck BMD and left hip BMD in postmenopausal women was analyzed by Pearson correlation analysis. The diagnostic efficacy of serum 25-(OH)D, DD and PINP in PMOP was analyzed by receiver operating characteristic (ROC) curve. 
Results The age [(59.98±3.49)years] and menopause duration [(7.28±2.39) years] of the osteoporosis group were significantly higher than those of the normal group [(52.76±3.87) years, (2.90±2.57) years] and the osteopenia group [(55.02±4.18) years, (4.52±2.99) years]. The total BMD of L1-4 [(0.730±0.064)g/cm2], femoral neck BMD[(0.680±0.057)g/cm2], and the total BMD of the left hip[(0.868±0.059)g/cm2] were significantly lower in the osteoporosis group compared with the normal group (P<0.05). The osteoporosis group had significantly higher age and menopause duration compared with the osteopenia group, and significantly lower total BMD of L1-4, femoral neck BMD, and total BMD of the left hip compared with the osteopenia group (P<0.05). The 25-(OH)D level [(17.70±7.28)μg/L] in the osteoporosis group was significantly lower than that in the osteopenia group [(21.15±4.88 )μg/L] and the normal group [(25.43±4.15)μg/L], while DD [(0.52±0.16)mg/L] and PINP [(67.94±15.76)μg/L] were significantly higher than those in the other two groups (P<0.05). The 25-(OH)D concentration in the osteoporosis group was significantly lower than that in the osteopenia group, while the DD and PINP concentrations were significantly higher than those in the osteopenia group (P<0.05). Pearson correlation analysis revealed that serum 25-(OH)D concentrations in postmenopausal women were positively correlated with total BMD of L1-4, femoral neck BMD, and total BMD of the left hip (P<0.001), while serum DD and PINP concentrations were negatively correlated with total BMD of L1-4, femoral neck BMD, and total BMD of the left hip (P<0.001). The are under the ROC curve (AUC) values of 25-(OH)D, DD, and PINP alone and in combination for the diagnosis were 0.765, 0.852, 0.712, and 0.968, respectively, and serum 25-(OH)D, DD, and PINP all had certain diagnostic value in diagnosing PMOP. The combined diagnosis had a sensitivity of 96.7% and specificity of 88.2%, and the combined diagnostic value was significantly better than the single diagnosis of each serum indicator (Z=7.036, 12.927, 5.219, 43.446, all P<0.05). 
Conclusion Serum 25-(OH)D, DD, and PINP levels are closely related to BMD in different body parts, and have certain diagnostic value in the diagnosis of PMOP, and the combined diagnostic value is higher. 


Key words: osteoporosis, postmenopause, calcifediol, D-dimer